EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease

Salim Maher, Jayashi Rajapakse, Emad El-Omar, Amany Zekry

Seminars in Liver Disease · 2024-11 · 44 (04) · 457-473

DOI: 10.1055/a-2438-4383 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 19.11.2024. Verfasst von Salim Maher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, St George Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 159 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD)—previously described as nonalcoholic fatty liver disease—continues to rise globally. Despite this, therapeutic measures for MASLD remain limited. Recently, there has been a growing interest in the gut microbiome's role in the pathogenesis of MASLD. Understanding this relationship may allow for the administration of therapeutics that target the gut microbiome and/or its metabolic function to alleviate MASLD development or progression. This review will discuss the interplay between the gut microbiome's structure and function in relation to the development of MASLD, assess the diagnostic yield of gut microbiome-based signatures as a noninvasive tool to identify MASLD severity, and examine current and emerging therapies targeting the gut microbiome–liver axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseHumansDysbiosisAnimalsLiver

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, St George Hospital, Sydney, Australia.
  • School of Clinical Medicine, UNSW Medicine & Health, St George & Sutherland Clinical Campuses.

Zitieren

APA

Maher, S., Rajapakse, J., El-Omar, E., & Zekry, A. (2024). Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease. Seminars in Liver Disease, 44(04), 457-473. https://doi.org/10.1055/a-2438-4383

Vancouver

Maher S, Rajapakse J, El-Omar E, Zekry A. Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease. Seminars in Liver Disease. 2024;44(04):457-473. doi:10.1055/a-2438-4383

BibTeX
@article{Maher2024,
  author = {Maher, Salim and Rajapakse, Jayashi and El-Omar, Emad and Zekry, Amany},
  title = {Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease},
  journal = {Seminars in Liver Disease},
  year = {2024},
  volume = {44},
  number = {04},
  pages = {457--473},
  doi = {10.1055/a-2438-4383}
}
Kostenlos starten →